Pricing Log in Create free account

TriSalus Life Sciences, Inc. (TLSI) vs Treace Medical Concepts, Inc. (TMCI)

TriSalus Life Sciences, Inc. and Treace Medical Concepts, Inc. are both Medical Devices companies. Treace Medical Concepts, Inc. is the larger, with a market value of $267.9M against $240.1M — 1.1× the size. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against −3.95%. Treace Medical Concepts, Inc. has the higher net margin (−29.0% vs −127.0%) and the lower return on invested capital (−43.0% vs 0.00%). Across the 17 metrics below, Treace Medical Concepts, Inc. leads on 11 and TriSalus Life Sciences, Inc. on 6.

Valuation

Metric TLSI TMCI Medical Devices median
P/E n/m n/m 23.22
P/S 4.69 1.23 2.34
P/B 32.31 3.72 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 4.41 1.29 2.24
Earnings yield (35.81%) (24.03%) (10.09%)
Free cash flow yield (11.33%) (9.95%) (8.47%)

Profitability

Metric TLSI TMCI Medical Devices median
Gross margin 85.79% 79.45% 56.01%
Operating margin (67.68%) (26.17%) (15.03%)
Net margin (127.00%) (28.99%) (20.40%)
Free cash flow margin (51.56%) (12.20%) (7.24%)
Return on equity 889.44% (71.99%) (15.32%)
Return on assets (110.34%) (30.72%) (19.72%)
Return on invested capital 0.00% (42.96%) (10.33%)

Growth

Metric TLSI TMCI Medical Devices median
Revenue growth (TTM) 25.25% (3.95%) 8.80%
EPS growth (last fiscal year) (40.46%) (3.33%) 29.03%
Revenue growth, 5-year CAGR — 29.96% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TLSI TMCI Medical Devices median
Debt to equity 5.05 0.83 0.07
Current ratio 5.35 2.90 2.50
Net debt to EBITDA (0.50) (0.17) 0.49

Dividend

Metric TLSI TMCI Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric TLSI TMCI Medical Devices median
Market cap 240.14m 267.94m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack